Skin Rejuvenation With Topical Extract and Other Nutraceuticals

Skin Rejuvenation Using Topical Hemp-based Extract and Other Nutraceuticals

Hemp extract has been shown in several pre-clinical and clinical studies to have anti-aging effects on the skin through anti-oxidant and anti-inflammatory effects, in addition resveratrol, thyme and caffeine have been shown to have anti-aging effects related to fibrillar collagen production and extracellular matrix production in the dermis.

A combination of these four ingredients will be used in a vehicle of fermented medium chain triglyceride oil and skin shave biopsies will be taken before and after 90 days use of the topical to look for objective evidence of anti-aging effects in the dermis and epidermis.

Study Overview

• Status: Recruiting
• Conditions: Wrinkle; Spot Pigmented; Lines Skin
• Intervention / Treatment: Drug: Nutraceutical Topical

Detailed Description

The study is a case series of 25 adults over age 50 identified through social media outreach in the Tampa Bay area. Each subject will be given a topical serum and advised to apply it once daily to the specific two by two inch area of skin under study (forearm or back of the neck). The serum will be comprised of hemp-extract, resveratrol, caffeine, thyme oil and fermented medium chain triglyceride as a vehicle. The skin anti-aging serum is expected to contain hemp-extract 5%, caffeine 2%, Thyme essential oil 2% and resveratrol 0.5%. The subjects will use the test formulation for 90 days. The subjects will jhave shaved skin biopsies taken on either the forearm or back of the neck. The biopsies will be done on day zero and on day 90.

None of the subjects are currently using anti-aging therapies. No other anti-aging therapy will be used during the 90 days of the research.

The subjects will be advised to apply a thin layer of the serum once each night at bedtime. To the area of skin under study (forearm or back of the neck). The one-ounce bottle of serum is expected to last for the entire 90 days of the study. The subjects will be reminded each day via text messaging to use the product and each subject will be required to text back that the daily treatment has been applied.

The 'before and after' shaved biopsies will be independently evaluated by Dr. Michael Morgan, board certified Dermatopathologist at KorPath, Inc. He will perform hematoxylin and eosin (H&E) staining, for histological analysis for morphology of the dermis and epidermis and histochemical staining for collagen and matrix analysis.

The subjects will be independently clinically evaluated by Dr. Kathy Anderson, board certified Dermatologist. She will determine "before and after" skin wrinkling scores using standard recognized metrics.

Each subject will have a diary app added to their smart phones to document daily use and potential adverse effects.

The results will be statistically evaluated with a standard for comparison. Study results with a p-value less than 0.05 will be determined to be statistically significant and the result will be evaluated for efficiency compared to generally recognized therapies

. The study will be prepared in standard fashion and submitted to recognized peer-review medical journals.

• Study Type: Interventional
• Enrollment (Anticipated): 25
• Phase: Early Phase 1

Contacts and Locations

• Study Contact: Name: Gregory L Smith, MD; Phone Number: 7278517972; Email: drsmith@nex-therapeutics.com
• Study Contact Backup: Name: Kathy Anderson, MD; Phone Number: 8137873180; Email: kathya@gmail.com

Study Locations

• United States
  • Florida
    • Clearwater, Florida, United States, 33762
      • Recruiting
      • Laser Scalp and Hair Center
      • Contact: Kathy Anderson, MD; Phone Number: 813-787-3180; Email: drsmith@nex-therapeutics.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Age 50 or over
• Glogau Wrinkle Severity Scale of either 3 or 4 on the area to be biopsied.
• Not on current anti-aging therapies used as an ingredient in the study topical.

Exclusion Criteria:

• Under age 50
• Glogau Wrinkle Severity Scale of either 1 or 2 on the area to be biopsied.
• Currently using anti-aging therapies used as an ingredient in the study topical.
• Contraindication to performing skin shave biopsies in the area to be biopsied.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Standard Topical Daily Dose; Only one arm in the study. Subjects treated with the topical daily for 90 days. The comparison will be 'before' and 'after' treatment skin biopsy results.	Drug: Nutraceutical Topical; Once daily application of the topical nutraceutical to two by two inch area of skin for 90 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
dermal-epidermal juncton flattening	Histologic appearance of dermal-epidermal flattening on 'before' and 'after' skin biopsies.	90 days
elastic fiber attenuation	Histologic appearance of elastic fiber attenuation in the dermis on 'before' and 'after' skin biopsies.	90 days
denisty of collagen fiber network	Histologic appearance of the density of the collagen fibers on 'before' and 'after' skin biopsies.	90 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Glogau System: Wrinkle Severity Ranking	Glogau System: Wrinkle Severity Ranking score from 1-4 on 'before' and 'after' dermatologist physical examination of treated area	90 days
Modified Fitzpatrick Wrinkle Scale	Modified Fitzpatrick Wrinkle Scale from class 0-2.5 on 'before' and 'after' dermatologist physical examination of treated area	90 days

Collaborators and Investigators

• Sponsor: Medical Life Care Planners, LLC
• Investigators: Principal Investigator: Gregory L Smith, MD, Nex Therapeutics, LLC

Publications and helpful links

General Publications

• Caverzan J, Mussi L, Sufi B, Padovani G, Nazato L, Camargo FB Junior, Magalhaes WV, Di Stasi LC. A new phytocosmetic preparation from Thymus vulgaris stimulates adipogenesis and controls skin aging process: In vitro studies and topical effects in a double-blind placebo-controlled clinical trial. J Cosmet Dermatol. 2021 Jul;20(7):2190-2202. doi: 10.1111/jocd.13818. Epub 2020 Nov 10.
• Costa EF, Magalhaes WV, Di Stasi LC. Recent Advances in Herbal-Derived Products with Skin Anti-Aging Properties and Cosmetic Applications. Molecules. 2022 Nov 3;27(21):7518. doi: 10.3390/molecules27217518.
• Few J, Lee MJ, Semersky A, Mariscal E, Vachon G. A Single-Center Study Evaluating the Effects of a Novel Retinol and Cannabidiol Combination Topical on Facial Skin. Aesthet Surg J Open Forum. 2022 Jan 27;4:ojac002. doi: 10.1093/asjof/ojac002. eCollection 2022.

Study record dates

Study Major Dates

• Study Start (Anticipated): March 1, 2023
• Primary Completion (Anticipated): June 1, 2023
• Study Completion (Anticipated): June 1, 2023

Study Registration Dates

• First Submitted: February 9, 2023
• First Submitted That Met QC Criteria: February 9, 2023
• First Posted (Estimate): February 20, 2023

Study Record Updates

• Last Update Posted (Estimate): February 20, 2023
• Last Update Submitted That Met QC Criteria: February 9, 2023
• Last Verified: February 1, 2023

More Information

Terms related to this study

• Keywords: caffeine; resveratrol; thyme; hemp extract
• Other Study ID Numbers: Skin Antiaging Effects

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: Yes
• Studies a U.S. FDA-regulated device product: No